Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer

Adoptive allogeneic natural killer (NK) cell therapy has shown promise in treating castration-resistant prostate cancer (CRPC), which is the terminal stage of prostate cancer (PCa) and incurable. Thus, we employed an efficient manufacturing method for the large-scale ex vivo expansion of high-qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangming, Dong, Xuejiao, Wang, Jing, Yang, Feiya, Liu, Donghua, Ma, Jianlin, Liu, Shuai, Chang, Dehua, Xing, Nianzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017519/
https://www.ncbi.nlm.nih.gov/pubmed/35450395
http://dx.doi.org/10.1155/2022/1786395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017519/
https://www.ncbi.nlm.nih.gov/pubmed/35450395
http://dx.doi.org/10.1155/2022/1786395

Ejemplares similares